← Back to Search

Internet-Based Intervention for Fertility Decisions in Cancer Patients

N/A
Waitlist Available
Led By Terri L Woodard
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Newly diagnosed breast tumor, female genital system tumor, colorectal tumor, and/or lymphoma/myeloma
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 months
Awards & highlights
No Placebo-Only Group

Summary

This trial studies a decision aid website to help make decisions about fertility in cancer patients. The website provides information about fertility preservation.

Who is the study for?
This trial is for people with certain cancers (like breast, colorectal, lymphoma/myeloma) who might face infertility due to treatment. Participants need internet access and an email address, must understand English, and haven't seen the Pathways decision aid before. Health care providers from a specific Houston location can also join.
What is being tested?
The study is testing if a website that helps with fertility decisions can assist cancer patients in choosing whether to preserve their ability to have children after treatment. It involves using the website and possibly filling out questionnaires.
What are the potential side effects?
Since this trial involves educational materials rather than medications or medical procedures, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been recently diagnosed with breast, genital, colorectal cancer, or lymphoma/myeloma.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patients' decisional conflict (Part 1)
Patients' decisional conflict (Part 2)
Secondary study objectives
Patients' decision-making process (Part 1)
Patients' decision-making process (Part 2)
Other study objectives
Acceptability of the decision aid website (Part 1)
Feasibility of the multicomponent DS intervention and research methods (Part 2)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm II (standard of care, decision-making website)Experimental Treatment4 Interventions
Participants receive standard of care as in Arm I. Participants also use the decision-making the website.
Group II: Arm I (standard of care)Active Control3 Interventions
Participants receive standard of care including education materials about fertility preservation from the Livestrong organization and a referral for fertility preservation, if requested.

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,066 Previous Clinical Trials
1,802,115 Total Patients Enrolled
147 Trials studying Breast Cancer
63,073 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,924 Previous Clinical Trials
41,017,821 Total Patients Enrolled
942 Trials studying Breast Cancer
1,443,237 Patients Enrolled for Breast Cancer
Terri L WoodardPrincipal InvestigatorM.D. Anderson Cancer Center
~7 spots leftby Apr 2025